Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Sundrug Co ( (JP:9989) ) is now available.
Sundrug Co., Ltd. reported a positive financial performance for the three months ending June 30, 2025, with a 6.7% increase in net sales and a 12.4% rise in operating profit compared to the previous year. The company maintains a stable financial position with a slight increase in equity ratio, indicating strong market positioning and potential growth, which is reassuring for stakeholders.
The most recent analyst rating on (JP:9989) stock is a Buy with a Yen4700.00 price target. To see the full list of analyst forecasts on Sundrug Co stock, see the JP:9989 Stock Forecast page.
More about Sundrug Co
Sundrug Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily operating in the retail industry. It focuses on the sale of pharmaceuticals and health-related products.
Average Trading Volume: 319,757
Technical Sentiment Signal: Buy
Current Market Cap: Yen552.8B
For detailed information about 9989 stock, go to TipRanks’ Stock Analysis page.